Overview

Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
Compare the viral load of hepatitis c virus in patients converted to certican versus patients who are maintained on calcineurin inhibitor.
Phase:
Phase 4
Details
Lead Sponsor:
Irmandade Santa Casa de Misericórdia de Porto Alegre
Collaborator:
Novartis
Treatments:
Calcineurin Inhibitors
Cyclosporine
Cyclosporins
Everolimus
Sirolimus
Tacrolimus